Cargando…
The Neutralizing Face of Hepatitis C Virus E2 Envelope Glycoprotein
The high genetic variability of hepatitis C virus, together with the high level of glycosylation on the viral envelope proteins shielding potential neutralizing epitopes, pose a difficult challenge for vaccine development. An effective hepatitis C virus (HCV) vaccine must target conserved epitopes a...
Autores principales: | Tzarum, Netanel, Wilson, Ian A., Law, Mansun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008530/ https://www.ncbi.nlm.nih.gov/pubmed/29951061 http://dx.doi.org/10.3389/fimmu.2018.01315 |
Ejemplares similares
-
Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis
por: Gopal, Radhika, et al.
Publicado: (2017) -
Genetic and structural insights into broad neutralization of hepatitis C virus by human V(H)1-69 antibodies
por: Tzarum, Netanel, et al.
Publicado: (2019) -
Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines
por: He, Linling, et al.
Publicado: (2020) -
From Structural Studies to HCV Vaccine Design
por: Yechezkel, Itai, et al.
Publicado: (2021) -
An alternate conformation of HCV E2 neutralizing face as an additional vaccine target
por: Tzarum, Netanel, et al.
Publicado: (2020)